IGLC1 is an independent prognostic marker and potent therapeutic target in osteosarcoma
IGLC1 is a novel independent prognostic marker that promotes tumor progression in osteosarcoma. Therapeutic strategies targeting IGLC1, such as inhibiting its expression or blocking its downstream signaling pathways, may provide innovative approaches for osteosarcoma treatment.
Authors
- Jinmin Zhao (ORCID: https://orcid.org/0000-0001-6478-5394)
- Zhenjie Wu (ORCID: https://orcid.org/0000-0002-6487-5207)
- Kevin Luong Ning (ORCID: https://orcid.org/0009-0001-3051-9968)
- Xiujie Xie (ORCID: https://orcid.org/0000-0002-3872-8051)
- Guangfu Shi
Institutions
- Guangxi Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1007/s12672-025-02653-6
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Guangxi Zhuang Autonomous Region